Literature DB >> 29323340

Osteoarthritis in 2017: Latest advances in the management of knee OA.

Timothy E McAlindon1, Raveendhara R Bannuru1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29323340     DOI： 10.1038/nrrheum.2017.219

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.

Authors:  Y Yazici; T E McAlindon; R Fleischmann; A Gibofsky; N E Lane; A J Kivitz; N Skrepnik; E Armas; C J Swearingen; A DiFrancesco; J R S Tambiah; J Hood; M C Hochberg
Journal:  Osteoarthritis Cartilage       Date:  2017-07-13       Impact factor: 6.576

2.  An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.

Authors:  Neil Bodick; Joelle Lufkin; Christina Willwerth; Anjali Kumar; James Bolognese; Chris Schoonmaker; Rahul Ballal; David Hunter; Michael Clayman
Journal:  J Bone Joint Surg Am       Date:  2015-06-03       Impact factor: 5.284

3.  OARSI guidelines for the non-surgical management of knee osteoarthritis.

Authors:  T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood
Journal:  Osteoarthritis Cartilage       Date:  2014-01-24       Impact factor: 6.576

4.  Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study.

Authors:  F M Cicuttini; G Jones; A Forbes; A E Wluka
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

Review 5.  Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials.

Authors:  Raveendhara R Bannuru; Timothy E McAlindon; Matthew C Sullivan; John B Wong; David M Kent; Christopher H Schmid
Journal:  Ann Intern Med       Date:  2015-09-01       Impact factor: 25.391

6.  A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

Authors:  V Deshmukh; H Hu; C Barroga; C Bossard; S Kc; L Dellamary; J Stewart; K Chiu; M Ibanez; M Pedraza; T Seo; L Do; S Cho; J Cahiwat; B Tam; J R S Tambiah; J Hood; N E Lane; Y Yazici
Journal:  Osteoarthritis Cartilage       Date:  2017-09-06       Impact factor: 6.576

7.  Risk factors for joint replacement in knee osteoarthritis; a 15-year follow-up study.

Authors:  Flemming K Nielsen; Niels Egund; Anette Jørgensen; Anne Grethe Jurik
Journal:  BMC Musculoskelet Disord       Date:  2017-12-04       Impact factor: 2.362

8.  Brief Report: A Phase IIb Trial of a Novel Extended-Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis.

Authors:  Philip G Conaghan; Stanley B Cohen; Francis Berenbaum; Joelle Lufkin; James R Johnson; Neil Bodick
Journal:  Arthritis Rheumatol       Date:  2017-12-20       Impact factor: 10.995

9.  Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.

Authors:  Timothy E McAlindon; Michael P LaValley; William F Harvey; Lori Lyn Price; Jeffrey B Driban; Ming Zhang; Robert J Ward
Journal:  JAMA       Date:  2017-05-16       Impact factor: 56.272
  9 in total
  5 in total

1.  Reduction in Osteoarthritis Risk After Treatment With Ticagrelor Compared to Clopidogrel: A Propensity Score-Matching Analysis.

Authors:  Matthew C Baker; Yingjie Weng; William H Robinson; Neera Ahuja; Nidhi Rohatgi
Journal:  Arthritis Rheumatol       Date:  2020-10-03       Impact factor: 10.995

Review 2.  Exercise to Mend Aged-tissue Crosstalk in Bone Targeting Osteoporosis & Osteoarthritis.

Authors:  Sarah E Little-Letsinger; Janet Rubin; Brian Diekman; Clinton T Rubin; Cody McGrath; Gabriel M Pagnotti; Eric L Klett; Maya Styner
Journal:  Semin Cell Dev Biol       Date:  2021-09-04       Impact factor: 7.727

Review 3.  Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.

Authors:  Yulin Chen; Xianmin Wu; Jiadong Li; Yingying Jiang; Ke Xu; Jiacan Su
Journal:  Front Pharmacol       Date:  2022-05-31       Impact factor: 5.988

4.  Harpagophytum procumbens Root Extract Mediates Anti-Inflammatory Effects in Osteoarthritis Synoviocytes through CB2 Activation.

Authors:  Alessia Mariano; Irene Bigioni; Roberto Mattioli; Antonella Di Sotto; Martina Leopizzi; Stefania Garzoli; Pier Francesco Mariani; Pietro Dalla Vedova; Sergio Ammendola; Anna Scotto d'Abusco
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-09

5.  lncRNA FER1L4 is dysregulated in osteoarthritis and regulates IL-6 expression in human chondrocyte cells.

Authors:  Jinhai He; Li Wang; Yajun Ding; Hongbing Liu; Guoyou Zou
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.